JPRN-UMIN000043098
Recruiting
未知
Study on Treatment of ulcerative colitis with infliximab originator and bio- Similar Targeting remission - TRUST study
Conditionsulcerative colitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ulcerative colitis
- Sponsor
- Sapporo Medical University
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients for whom a definitive diagnosis of ulcerative colitis has not been obtained 2\. Proctitis type patients 3\. Patients who have been administered either IFX / BS1 / BS2 in the past (However, cases in which treatment was discontinued after achieving remission by IFX / BS1 / BS2 treatment are excluded only when the same preparation is restarted due to relapse) 4\. Patients who have been treated with adalimumab or golimumab in the past and have been primarily ineffective 5\. Patients with a history of colectomy 6\. Patients with or have a history of malignant disease 7\. Patients with serious infectious diseases 8\. Others who are judged by the principal investigator to be inappropriate as research subjects
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Study on the treatment of ulcerative colitis in mild to moderate active stage by removing dampnesslcerative colitisITMCTR2000003426Guangdong Provincial Hospital of Chinese Medicine
Completed
Not Applicable
Biologica in patients with ulcerative colitis in Germany (BioColitis study)K51Ulcerative colitisDRKS00009219CED Service GmbH885
Completed
Not Applicable
Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximabJPRN-UMIN000020402IBD Relapse Prevention Team50
Terminated
Not Applicable
Maintaining Remission of Ulcerative Colitis with Faecal Microbiota Transplantation: the MR-UC-FMT Triallcerative ColitisInflammatory Bowel DiseaseUlcerative ColitisOral and Gastrointestinal - Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesACTRN12622001434785Central Adelaide Local Health Network36
Recruiting
Not Applicable
Better control and treatment of Ulcerative Colitis (UC) by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsiesNL-OMON54471Radboud Universitair Medisch Centrum40